Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Genitourinary 2CNS 2Other solid neoplasm 1Myeloid 1Gastrointestinal 1

Conditions

Sarcoma 9Rhabdomyosarcoma 4Rhabdoid Tumor 4Osteosarcoma 4Central Nervous System Neoplasms 4Brain Neoplasms 4Neuroectodermal Tumors, Primitive, Peripheral 3Neuroblastoma 3Medulloblastoma 3Testicular Neoplasms 2Testicular Germ Cell Tumor 2Spinal Cord Neoplasms 2Sarcoma, Ewing 2Ovarian Neoplasms 2Neoplasms, Germ Cell and Embryonal 2Kidney Neoplasms 2Choroid Plexus Neoplasms 2Carcinoma, Renal Cell 2Astrocytoma 2Wilms Tumor 1Urinary Bladder Neoplasms 1Teratoma 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Kaposi 1Retinoblastoma 1Recurrence 1Pinealoma 1Ovarian Germ Cell Cancer 1Optic Nerve Glioma 1

Interventions

Cyclophosphamide 4Sirolimus 3pembrolizumab 2fludarabine 2etoposide phosphate 2Mesna 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Celecoxib 2Busulfan 2ripretinib 1repotrectinib 1pegylated granulocyte colony-stimulating factor 1interferon gamma-1b 1fludarabine phosphate 1bintrafusp alfa protein, human 1Vorinostat 1Ursodeoxycholic Acid 1Topotecan 1Thrombopoietin 1Thiotepa 1Therapeutics 1Tetrahydrouridine 1Stem Cell Transplantation 1Simvastatin 1Radiotherapy, Image-Guided 1Radiation 1Psychiatric Rehabilitation 1Plicamycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms, Germ Cell and Embryonal × etoposide phosphate × Sarcoma × Clear all
NCT02574728 2026-03-02

AflacST1502

Emory University

Phase 2 Active not recruiting
46 enrolled
CNSMyeloidSarcoma

Brain Neoplasms, Carcinoma, Ependymoma, Histiocytosis, Langerhans-Cell, Medulloblastoma, Neoplasms, Neoplasms, Germ Cell and Embryonal, Neuroblastoma, Pinealoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Rhabdoid Tumor

NCT01505569 2024-02-26

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

Masonic Cancer Center, University of Minnesota

Phase NA Completed
44 enrolled
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Brain Neoplasms, Carcinoma, Renal Cell, Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡